Development and Evaluation of Sustained Release Lipid Nanocarriers for Curcumin

Page: [224 - 235] Pages: 12

  • * (Excluding Mailing and Handling)

Abstract

Background: Lipid based excipients have increased acceptance nowadays in the development of novel drug delivery systems in order to improve their pharmacokinetic profiles. Drugs encapsulated in lipids have enhanced stability due to the protection they experience in the lipid core of these nano-formulations. Phytosomes are newly discovered drug delivery systems and novel botanical formulation to produce lipophilic molecular complex which imparts stability, increases absorption and bioavailability of phytoconstituent. Curcumin, obtained from turmeric (Curcuma longa), has a wide range of biological activities. The poor solubility and wettability of curcumin are responsible for poor dissolution and this, in turn, results in poor bioavailability. To overcome these limitations, the curcumin-loaded nano phytosomes were developed to improve its physicochemical stability and bioavailability.

Objective: The objective of the present research work was to develop nano-phytosomes of curcumin to improve its physicochemical stability and bioavailability.

Methods: Curcumin-loaded nano phytosomes were prepared by using phospholipid Phospholipon 90 H using a modified solvent evaporation method. The developed curcumin nano phytosomes were evaluated by particle size analyzer and differential scanning calorimetry (DSC).

Results: Results indicated that phytosomes prepared using curcumin and lipid in the ratio of 1:2 show good entrapment efficiency. The obtained curcumin phytosomes were spherical in shape with a size less than 100 nm. The prepared nano phytosomal formulation of curcumin showed promising potential as an antioxidant.

Conclusion: The phytosomal complex showed sustained release of curcumin from vesicles. The sustained release of curcumin from phytosome may improve its absorption and lowers the elimination rate with an increase in bioavailability.

Keywords: Phytosomes, curcumin, soyabean phospholipid, antioxidant, zingiberaceae, phospholipon 90 H.

Graphical Abstract

[1]
Wilken R, Mysore S. Veena, Marilene B Wang, Eri S Srivatsan. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 2011; 10(1): 12.
[2]
Ghatak N, Basu N. Sodium curcuminate as an effective anti-inflammatory agent. Indian J Exp Biol 1972; 10(3): 235-6.
[PMID: 4651248]
[3]
Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem 1999; 47(10): 4297-300.
[http://dx.doi.org/10.1021/jf990308d] [PMID: 10552805]
[4]
Apisariyakul A, Vanittanakom N, Buddhasukh D. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol 1995; 49(3): 163-9.
[http://dx.doi.org/10.1016/0378-8741(95)01320-2] [PMID: 8824742]
[5]
Bansar N, Basant D. Curcumin as an effective Chemopreventive agent. Indian J Exp Biol 1982; 11: 115-211.
[6]
Itthipanichpong C, Ruangrungsi N, Kemsri W, Sawasdipanich A. Antispasmodic effects of curcuminoids on isolated guinea-pig ileum and rat uterus. J Med Assoc Thai 2003; 86(Suppl. 2): S299-309.
[PMID: 12930003]
[7]
Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995; 94(1): 79-83.
[http://dx.doi.org/10.1016/0304-3835(95)03827-J] [PMID: 7621448]
[8]
Dhar ML, Dhar MM, Dhawan BN. Mehrotra BN andRay C. Screening of Indian plants for biologicalactivity. Indian J Exp Biol 1968; 6: 232-47.
[PMID: 5720682]
[9]
Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 1995; 49(8): 1165-70.
[http://dx.doi.org/10.1016/0006-2952(95)98514-A] [PMID: 7748198]
[10]
Ali Hussain HE, Ali H. Hypoglycemic, hypolipidemic and antioxidant properties of combination ofCurcumin fromCurcuma longa, Linn, and partially purified product fromAbroma augusta, Linn. in streptozotocin induced diabetes. Indian J Clin Biochem 2002; 17(2): 33-43.
[http://dx.doi.org/10.1007/BF02867969] [PMID: 23105348]
[11]
Garg SK. Effect of Curcuma longa (rhizomes) on fertility in experimental animals. Planta Med 1974; 26(3): 225-7.
[http://dx.doi.org/10.1055/s-0028-1099381] [PMID: 4427957]
[12]
Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer 2005; 41(13): 1955-68.
[http://dx.doi.org/10.1016/j.ejca.2005.05.009] [PMID: 16081279]
[13]
Fadus MC, Lau C, Bikhchandani J, Lynch HT. Curcumin: An age-old anti-inflammatory and anti-neoplastic agent. J Tradit Complement Med 2016; 7(3): 339-46.
[http://dx.doi.org/10.1016/j.jtcme.2016.08.002] [PMID: 28725630]
[14]
Wang YJ, Pan MH, Cheng AL, et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997; 15(12): 1867-76.
[http://dx.doi.org/10.1016/S0731-7085(96)02024-9] [PMID: 9278892]
[15]
Jovanovic SV, Steenken S, Boone CW. H-Atom transfer is a preferred antioxidant mechanism of curcumin. J Am Chem Soc 1999; 21: 677-81.
[http://dx.doi.org/10.1021/ja991446m]
[16]
Modasiya M K, Patel V M. Studies on solubility of curcumin Int J of Pharm and Life Sci (IJPLS) 2012; 3: 1490-7.
[17]
Gangaitanurava BT. Validated method for the estimation of curcumin in turmeric powder. Indian J Tradit Knowl 2011; 10(2): 247-50.
[18]
Tønnesen HH, Másson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 2002; 244(1-2): 127-35.
[http://dx.doi.org/10.1016/S0378-5173(02)00323-X] [PMID: 12204572]
[19]
Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 853(1-2): 183-9.
[http://dx.doi.org/10.1016/j.jchromb.2007.03.010] [PMID: 17400527]
[20]
Shrestha H, Bala R, Arora S. Lipid-based drug delivery systems. J Pharm (Cairo) 2014; 2014801820
[http://dx.doi.org/10.1155/2014/801820] [PMID: 26556202]
[21]
Sharma D, Bhujbale AA. Phytosomes is a novel drug delivery system based herbal formulation: an review. PharmaTutor 2018; 6(3): 23-6.
[http://dx.doi.org/10.29161/PT.v6.i3.2018.23]
[22]
Awasthi R, Kulkarni GT, Pawar VK. Phytosomes: an approach to increase the bioavailability of plant extracts. Int J Pharm Pharm Sci 2011; 3(2): 1-3.
[23]
Saha S, Sarma A, Saikia P, Chakrabarty T. Phytosome: a Brief Overview. Scholars Aca J Pharm 2013; 2: 12-20.
[24]
Anitha A, Deepagan VG, Rani VV, Menon D, Nair SV, Jayakumar R. Preparation, characterization, in vitroitalic> drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles. Carbohydr Polym 2011; 84(3): 1158-64.
[http://dx.doi.org/10.1016/j.carbpol.2011.01.005]
[25]
Hintz R, Johnson K. The Effect of Particle Size Distribution on Dissolution Rate and Oral Absorption. Int J Pharm 1989; 51(1): 9-17.
[http://dx.doi.org/10.1016/0378-5173(89)90069-0]
[26]
Shirwaikar A, Prabhu KS, Punitha ISR. In vitro antioxidant studies of Sphaeranthus indicus (Linn). Indian J Exp Biol 2006; 44(12): 993-6.
[PMID: 17176673]
[27]
Shyam KR, Mruthunjaya K, Gupta MK. Preparation, Characterization and Antioxidant Activities of Gallic Acid-Phospholipids Complex. IJRPS 2012; 2(1): 138-48.
[28]
Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963; 52: 1145-9.
[http://dx.doi.org/10.1002/jps.2600521210] [PMID: 14088963]
[29]
Korsmeyer RW, Gurny R, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983; 15: 25-35.
[http://dx.doi.org/10.1016/0378-5173(83)90064-9]
[30]
Phosphatidylcholine. Altern Med Rev 2002; 7(2): 150-4.
[PMID: 11991794]
[31]
Rahman Z, Zidan AS, Habib MJ, Khan MA. Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design. Int J Pharm 2010; 389(1-2): 186-94.
[http://dx.doi.org/10.1016/j.ijpharm.2009.12.040] [PMID: 20038446]
[32]
Chaudhari RTM. A Novel approach towards phytosomal flavonoids. Pharma Sci Monitor 2012; 3(3): 3947-63.